Obesity adversely impacts disease specific outcomes in patients with upper tract urothelial carcinoma.
暂无分享,去创建一个
W. Lowrance | Y. Lotan | V. Margulis | S. Shariat | P. Karakiewicz | J. Raman | G. Novara | Richard Lee | D. Scherr | B. Ehdaie | T. Chromecki | C. Ng | R. Lee
[1] M. Kuczyk,et al. Obesity is associated with improved survival in patients with organ-confined clear-cell kidney cancer , 2010, Cancer Causes & Control.
[2] W. Lowrance,et al. Obesity is associated with a higher risk of clear‐cell renal cell carcinoma than with other histologies , 2010, BJU international.
[3] C. Ulrich,et al. The effects of obesity and obesity-related conditions on colorectal cancer prognosis. , 2010, Cancer control : journal of the Moffitt Cancer Center.
[4] F. Montorsi,et al. Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients. , 2009, European journal of cancer.
[5] Y. Lotan,et al. Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration , 2009, Cancer.
[6] S. Franceschi,et al. Effect of obesity and other lifestyle factors on mortality in women with breast cancer , 2008, International journal of cancer.
[7] M. Terris,et al. Obesity and oncological outcome after radical prostatectomy: impact of prostate‐specific antigen‐based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center Databases , 2008, BJU international.
[8] C. Koebnick,et al. Body Mass Index, Physical Activity, and Bladder Cancer in a Large Prospective Study , 2008, Cancer Epidemiology Biomarkers & Prevention.
[9] M. Stampfer,et al. Prospective study of body mass index, height, physical activity and incidence of bladder cancer in US men and women , 2007, International journal of cancer.
[10] A. Jemal,et al. Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.
[11] J. Cheville,et al. Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma. , 2006, Urology.
[12] J. Klenk,et al. Obesity and incidence of cancer: a large cohort study of over 145 000 adults in Austria , 2005, British Journal of Cancer.
[13] R J Jarrett,et al. Obesity and overweight in relation to organ-specific cancer mortality in London (UK): findings from the original Whitehall study , 2005, International Journal of Obesity.
[14] J. Bartlett,et al. The relationship between the systemic inflammatory response and survival in patients with transitional cell carcinoma of the urinary bladder , 2005, British Journal of Cancer.
[15] B. Bochner,et al. Does body mass index affect survival of patients undergoing radical or partial cystectomy for bladder cancer? , 2004, The Journal of urology.
[16] R. Hoover,et al. Obesity and cancer risk among white and black United States veterans , 2004, Cancer Causes & Control.
[17] S. Wen,et al. Association of obesity and cancer risk in Canada. , 2004, American journal of epidemiology.
[18] P. Sluss,et al. Characterization of insulin-like growth factor I binding sites in human bladder cancer cell lines , 2004, Urological Research.
[19] H. Adami,et al. A prospective study of obesity and cancer risk (Sweden) , 2004, Cancer Causes & Control.
[20] Michael J Thun,et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.
[21] Shahrokh F. Shariat,et al. C: IGF-I l IGFBP-3 l ☆ , 2003 .
[22] T. Wheeler,et al. Correlation of preoperative levels of IGF-I and IGFBP-3 with pathologic parameters and clinical outcome in patients with bladder cancer. , 2003, Urology.
[23] K. Flegal,et al. Prevalence and trends in obesity among US adults, 1999-2000. , 2002, JAMA.
[24] T. Wheeler,et al. Preoperative plasma levels of interleukin-6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer. , 2002, The Journal of urology.
[25] F Vinicor,et al. The continuing epidemics of obesity and diabetes in the United States. , 2001, JAMA.
[26] A. Astrup,et al. Obesity : Preventing and managing the global epidemic , 2000 .
[27] A. R. Frisancho. Physical Status: The Use and Interpretation of Anthropometry , 1996, The American Journal of Clinical Nutrition.
[28] P. B. Eveleth,et al. Physical Status: The Use and Interpretation of Anthropometry. Report of a WHO Expert Committee , 1996 .
[29] J. Olsen,et al. Obesity and cancer risk: a Danish record-linkage study. , 1994, European journal of cancer.
[30] P. Deurenberg,et al. Body mass index as a measure of body fatness: age- and sex-specific prediction formulas , 1991, British Journal of Nutrition.
[31] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[32] M. Seppälä,et al. Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. , 1988, The Journal of clinical endocrinology and metabolism.